Back to news
researchAnthropicExin Therapeutics2026-11-01

Startup performs brain surgery on epileptic mouse with Anthropic Sonnet driving the robotic arm while Opus 5.5 refused

Exin Therapeutics, a biotech startup focused on next-generation neurotherapeutics, said this week it successfully let an AI agent perform brain surgery on a mouse.

Exin Therapeutics, a biotech startup focused on next-generation neurotherapeutics, said this week it successfully let an AI agent perform brain surgery on a mouse. Co-founder and chief executive Gabriel Ocana-Santero shared the process on X, showing how the agent selected the gene therapy vector, dose and brain region. The agent drove a robotic arm to inject the drug into the mouse's brain, and the outcome appears successful with good recovery. The team used Anthropic's Sonnet model, giving it a spreadsheet of 19 gene therapy vectors, an epileptic mouse model, a robotic surgical rig with a camera and the goal of reducing seizures. The model chose the drug and brain region on its own, derived coordinates from three papers, drove the arm, watched the camera feed for bleeding at the injection site and delivered 250 nanoliters of drug. A veterinarian supervised, every irreversible step required approval, and an emergency stop can cut power to all motors. The AI handled only the injection while human surgeons did the craniotomy and suturing. The company had preferred Opus 5.5, but that model refused outright on detecting biological content, reasoning that being cut off mid-surgery with a needle left in the brain would be worse than not starting.

AnthropicSonnet神经科学脑部手术智能体生物安全